Whole blood gene expression can distinguish benign from malignant lung nodules transitioning from microarrays to a nanostring platform
Ontology highlight
ABSTRACT: Development of a non-invasive, whole blood microarray gene expression signature that accurately distinguishes malignant from benign lung nodules detected by LDCT and the successful transition of that signature to a custom NanoString panel with no loss of accuracy.
ORGANISM(S): Homo sapiens
PROVIDER: GSE108375 | GEO | 2018/12/20
REPOSITORIES: GEO
ACCESS DATA